BACKGROUND: L-type calcium channels (LTCCs) play important roles in regulating cardiomyocyte physiology, which is governed by appropriate LTCC trafficking to and density at the cell surface. Factors influencing the expression, half-life, subcellular trafficking, and gating of LTCCs are therefore critically involved in conditions of cardiac physiology and disease. METHODS: Yeast 2-hybrid screenings, biochemical and molecular evaluations, protein interaction assays, fluorescence microscopy, structural molecular modeling, and functional studies were used to investigate the molecular mechanisms through which the LTCC Ca-v beta 2 chaperone regulates channel density at the plasma membrane. RESULTS: On the basis of our previous results, we found a direct linear correlation between the total amount of the LTCC pore-forming Ca-v alpha 1.2 and the Akt-dependent phosphorylation status of Ca-v beta 2 both in a mouse model of diabetic cardiac disease and in 6 diabetic and 7 nondiabetic cardiomyopathy patients with aortic stenosis undergoing aortic valve replacement. Mechanistically, we demonstrate that a conformational change in Ca-v beta 2 triggered by Akt phosphorylation increases LTCC density at the cardiac plasma membrane, and thus the inward calcium current, through a complex pathway involving reduction of Ca-v alpha 1.2 retrograde trafficking and protein degradation through the prevention of dynaminmediated LTCC endocytosis; promotion of Ca-v alpha 1.2 anterograde trafficking by blocking Kir/ Gem-dependent sequestration of Ca-v beta 2, thus facilitating the chaperoning of Ca-v alpha 1.2; and promotion of Ca-v alpha 1.2 transcription by the prevention of Kir/Gem-mediated shuttling of Ca-v beta 2 to the nucleus, where it limits the transcription of Ca-v alpha 1.2 through recruitment of the heterochromatin protein 1. epigenetic repressor to the Cacna1c promoter. On the basis of this mechanism, we developed a novel mimetic peptide that, through targeting of Ca-v beta 2, corrects LTCC lifecycle alterations, facilitating the proper function of cardiac cells. Delivery of mimetic peptide into a mouse model of diabetic cardiac disease associated with LTCC abnormalities restored impaired calcium balance and recovered cardiac function. CONCLUSIONS: We have uncovered novel mechanisms modulating LTCC trafficking and life cycle and provide proof of concept for the use of Ca-v beta 2 mimetic peptide as a novel therapeutic tool for the improvement of cardiac conditions correlated with alterations in LTCC levels and function.

Peptidomimetic Targeting of Cavβ2 Overcomes Dysregulation of the L-Type Calcium Channel Density and Recovers Cardiac Function

MIRAGOLI, MICHELE;TESSARI, Maddalena;FAGGIAN, Giuseppe;CONDORELLI, GIANLUIGI;
2016-01-01

Abstract

BACKGROUND: L-type calcium channels (LTCCs) play important roles in regulating cardiomyocyte physiology, which is governed by appropriate LTCC trafficking to and density at the cell surface. Factors influencing the expression, half-life, subcellular trafficking, and gating of LTCCs are therefore critically involved in conditions of cardiac physiology and disease. METHODS: Yeast 2-hybrid screenings, biochemical and molecular evaluations, protein interaction assays, fluorescence microscopy, structural molecular modeling, and functional studies were used to investigate the molecular mechanisms through which the LTCC Ca-v beta 2 chaperone regulates channel density at the plasma membrane. RESULTS: On the basis of our previous results, we found a direct linear correlation between the total amount of the LTCC pore-forming Ca-v alpha 1.2 and the Akt-dependent phosphorylation status of Ca-v beta 2 both in a mouse model of diabetic cardiac disease and in 6 diabetic and 7 nondiabetic cardiomyopathy patients with aortic stenosis undergoing aortic valve replacement. Mechanistically, we demonstrate that a conformational change in Ca-v beta 2 triggered by Akt phosphorylation increases LTCC density at the cardiac plasma membrane, and thus the inward calcium current, through a complex pathway involving reduction of Ca-v alpha 1.2 retrograde trafficking and protein degradation through the prevention of dynaminmediated LTCC endocytosis; promotion of Ca-v alpha 1.2 anterograde trafficking by blocking Kir/ Gem-dependent sequestration of Ca-v beta 2, thus facilitating the chaperoning of Ca-v alpha 1.2; and promotion of Ca-v alpha 1.2 transcription by the prevention of Kir/Gem-mediated shuttling of Ca-v beta 2 to the nucleus, where it limits the transcription of Ca-v alpha 1.2 through recruitment of the heterochromatin protein 1. epigenetic repressor to the Cacna1c promoter. On the basis of this mechanism, we developed a novel mimetic peptide that, through targeting of Ca-v beta 2, corrects LTCC lifecycle alterations, facilitating the proper function of cardiac cells. Delivery of mimetic peptide into a mouse model of diabetic cardiac disease associated with LTCC abnormalities restored impaired calcium balance and recovered cardiac function. CONCLUSIONS: We have uncovered novel mechanisms modulating LTCC trafficking and life cycle and provide proof of concept for the use of Ca-v beta 2 mimetic peptide as a novel therapeutic tool for the improvement of cardiac conditions correlated with alterations in LTCC levels and function.
calcium; calcium channels; L-type; cardiovascular diseases; diabetic cardiomyopathies; drug therapy; peptides; protein transport
calcium, calcium channels L-type, cardiovascular diseases, diabetic cardiomyopathies, drug therapy, peptides, protein transport, Amino Acid Sequence, Animals, Biomimetic Materials, Calcium Channels L-Type, Cardiovascular Diseases, Cells Cultured, Drug Delivery Systems, Female, HEK293 Cells, Humans, Male, Mice, Mice Inbred C57BL, Myocytes Cardiac, Peptidomimetics, Protein Structure Secondary, Protein Structure Tertiary, Retrospective Studies
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/971522
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 31
social impact